SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Petmed Express Inc. – ‘10-K’ for 3/31/21 – ‘EX-23.1’

On:  Tuesday, 5/25/21, at 7:35am ET   ·   For:  3/31/21   ·   Accession #:  1437749-21-13213   ·   File #:  0-28827

Previous ‘10-K’:  ‘10-K’ on 5/26/20 for 3/31/20   ·   Next:  ‘10-K’ on 5/24/22 for 3/31/22   ·   Latest:  ‘10-K/A’ on 4/15/24 for 3/31/23   ·   14 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/25/21  Petmed Express Inc.               10-K        3/31/21   67:5.5M                                   RDG Filings/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    744K 
 2: EX-21.1     Subsidiaries List                                   HTML     19K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     19K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
13: R1          Document And Entity Information                     HTML     79K 
14: R2          Consolidated Balance Sheets                         HTML     98K 
15: R3          Consolidated Balance Sheets (Parentheticals)        HTML     41K 
16: R4          Consolidated Statements of Income                   HTML     91K 
17: R5          Consolidated Statements of Changes in               HTML     58K 
                Shareholders' Equity                                             
18: R6          Consolidated Statements of Cash Flows               HTML     90K 
19: R7          Note 1 - Summary of Significant Accounting          HTML     98K 
                Policies                                                         
20: R8          Note 2 - Property and Equipment                     HTML     37K 
21: R9          Note 3 - Valuation and Qualifying Accounts          HTML     32K 
22: R10         Note 4 - Accrued Expenses and Other Current         HTML     35K 
                Liabilities                                                      
23: R11         Note 5 - Income Taxes                               HTML     64K 
24: R12         Note 6 - Shareholders' Equity                       HTML     35K 
25: R13         Note 7 - Restricted Stock                           HTML     37K 
26: R14         Note 8 - Fair Value Measurements                    HTML     26K 
27: R15         Note 9 - Net Income Per Share                       HTML     41K 
28: R16         Note 10 - Commitments and Contingencies             HTML     29K 
29: R17         Note 11 - Employee Benefit Plan                     HTML     24K 
30: R18         Note 12 - COVID-19                                  HTML     24K 
31: R19         Note 13 - Related Party Transaction                 HTML     24K 
32: R20         Note 14 - Subsequent Events                         HTML     23K 
33: R21         Note 15 - Quarterly Financial Data (Unaudited)      HTML     53K 
34: R22         Significant Accounting Policies (Policies)          HTML    133K 
35: R23         Note 1 - Summary of Significant Accounting          HTML     70K 
                Policies (Tables)                                                
36: R24         Note 2 - Property and Equipment (Tables)            HTML     36K 
37: R25         Note 3 - Valuation and Qualifying Accounts          HTML     31K 
                (Tables)                                                         
38: R26         Note 4 - Accrued Expenses and Other Current         HTML     34K 
                Liabilities (Tables)                                             
39: R27         Note 5 - Income Taxes (Tables)                      HTML     64K 
40: R28         Note 6 - Shareholders' Equity (Tables)              HTML     28K 
41: R29         Note 7 - Restricted Stock (Tables)                  HTML     31K 
42: R30         Note 9 - Net Income Per Share (Tables)              HTML     39K 
43: R31         Note 15 - Quarterly Financial Data (Unaudited)      HTML     51K 
                (Tables)                                                         
44: R32         Note 1 - Summary of Significant Accounting          HTML     42K 
                Policies (Details Textual)                                       
45: R33         Note 1 - Summary of Significant Accounting          HTML     48K 
                Policies - Disaggregation of Revenue by Type                     
                (Details)                                                        
46: R34         Note 2 - Property and Equipment - Major             HTML     35K 
                Classifications of Property and Equipment                        
                (Details)                                                        
47: R35         Note 3 - Valuation and Qualifying Accounts -        HTML     25K 
                Activity in the Valuation and Qualifying Accounts                
                (Details)                                                        
48: R36         Note 4 - Accrued Expenses and Other Current         HTML     42K 
                Liabilities - Major Classifications of Accrued                   
                Expenses and Other Current Liabilities (Details)                 
49: R37         Note 5 - Income Taxes (Details Textual)             HTML     27K 
50: R38         Note 5 - Income Taxes - Deferred Income Taxes       HTML     35K 
                (Details)                                                        
51: R39         Note 5 - Income Taxes - Components of Income Tax    HTML     41K 
                Provision (Details)                                              
52: R40         Note 5 - Income Taxes - Reconciliation of Income    HTML     32K 
                Tax Provision (Details)                                          
53: R41         Note 6 - Shareholders' Equity (Details Textual)     HTML     55K 
54: R42         Note 6 - Shareholder's Equity - Declared Dividends  HTML     41K 
                (Details)                                                        
55: R43         Note 7 - Restricted Stock (Details Textual)         HTML     58K 
56: R44         Note 7 - Restricted Stock - Non-vested Restricted   HTML     34K 
                Stock (Details)                                                  
57: R45         Note 9 - Net Income Per Share (Details Textual)     HTML     20K 
58: R46         Note 9 - Net Income Per Share - Basic and Diluted   HTML     57K 
                Net Income Per Share (Details)                                   
59: R47         Note 10 - Commitments and Contingencies (Details    HTML     53K 
                Textual)                                                         
60: R48         Note 11 - Employee Benefit Plan (Details Textual)   HTML     24K 
61: R49         Note 13 - Related Party Transaction (Details        HTML     26K 
                Textual)                                                         
62: R50         Note 14 - Subsequent Events (Details Textual)       HTML     30K 
63: R51         Note 15 - Quarterly Financial Data (Unaudited) -    HTML     47K 
                Summarized Unaudited Quarterly Financial Data                    
                (Details)                                                        
65: XML         IDEA XML File -- Filing Summary                      XML    120K 
12: XML         XBRL Instance -- pets20210331_10k_htm                XML   1.14M 
64: EXCEL       IDEA Workbook of Financial Reports                  XLSX     61K 
 8: EX-101.CAL  XBRL Calculations -- pets-20210331_cal               XML    121K 
 9: EX-101.DEF  XBRL Definitions -- pets-20210331_def                XML    829K 
10: EX-101.LAB  XBRL Labels -- pets-20210331_lab                     XML    700K 
11: EX-101.PRE  XBRL Presentations -- pets-20210331_pre              XML    873K 
 7: EX-101.SCH  XBRL Schema -- pets-20210331                         XSD    135K 
66: JSON        XBRL Instance as JSON Data -- MetaLinks              264±   411K 
67: ZIP         XBRL Zipped Folder -- 0001437749-21-013213-xbrl      Zip    216K 


‘EX-23.1’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <>  <>  C:  <> 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in these Registration Statements (No. 333-218917, No. 333-145179, No. 333-145180) on Form S-8 and related Reoffer Prospectus of PetMed Express, Inc. of our reports dated May 25, 2021, relating to the consolidated financial statements of PetMed Express, Inc., and the effectiveness of internal control over financial reporting appearing in the Annual Report on Form 10-K of PetMed Express, Inc. for the year ended March 31, 2021.

 

We also consent to the reference to our firm under the heading “Experts” in such Reoffer Prospectus.

 

/s/ RSM US LLP

West Palm Beach, Florida

May 25, 2021

 

 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:5/25/213,  8-K
For Period end:3/31/21
 List all Filings 


14 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/20  Petmed Express Inc.               8-K:5,9     7/31/20    2:50K                                    RDG Filings/FA
 5/26/20  Petmed Express Inc.               10-K        3/31/20   65:5M                                     RDG Filings/FA
 3/26/20  Petmed Express Inc.               8-K:5,9     3/24/20    2:303K                                   RDG Filings/FA
 7/12/19  Petmed Express Inc.               8-K:5,9     7/12/19    2:43K                                    RDG Filings/FA
 5/13/19  Petmed Express Inc.               8-K:5,9     5/13/19    2:52K                                    RDG Filings/FA
10/31/17  Petmed Express Inc.               10-Q        9/30/17   38:1.8M                                   RDG Filings/FA
 5/23/17  Petmed Express Inc.               10-K        3/31/17   70:3.5M                                   Toppan Vite NY Inc./FA
 6/13/16  Petmed Express Inc.               DEF 14A     7/29/16    1:509K                                   Toppan Vite NY Inc./FA
 2/02/16  Petmed Express Inc.               10-Q       12/31/15   40:1.8M                                   Toppan Vite NY Inc./FA
 6/08/15  Petmed Express Inc.               DEF 14A     7/24/15    1:592K                                   Toppan Vite NY Inc./FA
 5/22/15  Petmed Express Inc.               10-K        3/31/15   72:6.7M                                   Toppan Vite NY Inc./FA
 4/07/09  Petmed Express Inc.               8-K:8,9     4/07/09    2:22K                                    Elec Filings Inc./FA
 3/30/01  Petmed Express Inc.               8-K:5,7     3/16/01    2:39K                                    Bowne of Atlanta Inc./FA
 1/10/00  Petmed Express Inc.               10SB12G               17:733K                                   Global Fin’l Press/FL/FA
Top
Filing Submission 0001437749-21-013213   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:41:49.1am ET